Pain Therapeutics reported $-17527000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US $ 3899M 1051M
Acelrx Pharmaceuticals ACRX:US $ -8.67M 0.76M
Amgen AMGN:US $ 2727M 56M
Biogen BIIB:US $ 903.4M 316.6M
Cara Therapeutics CARA:US $ -27749000 5.63M
Eisai 4523:JP Y -20779M 34669M
Geron GERN:US $ -30.1M 1.92M
Johnson & Johnson JNJ:US $ 8218M 1879M
Merk MRK:US $ 6309M 1525M
Novartis NOVN:VX SF 3912M 230M
Novavax NVAX:US $ 206.07M 1035.74M
Pain Therapeutics PTIE:US $ -17.53M 3.36M
Pfizer PFE:US $ 11328M 4083M